Pyxis Oncology Inc is trading 8.2% up at $2.06 today, extending a multi-day rebound from last week’s levels on relatively light, news-thin action.
- The move appears to be a continuation of recent speculative buying within the biotech sector rather than a reaction to a specific new catalyst.
- No fresh company filings, press releases, analyst calls, or FDA/clinical headlines have been reported so far this morning.